Randomized Phase 3 Trial of Regorafenib in Patients (Patients) with Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) Progressing Despite Prior Treatment with at Least Imatinib (IM) and Sunitinib (SU) : Grid Trial
Toshirou NishidaPaolo G. CasaliPeter ReichardtYoon‐Koo KangJean‐Yves BlayHeikki JoensuuRobert G. MakiPiotr RutkowskiPeter HohenbergerHans GelderblomMichael LeahyMargaret von MehrenPatrick SchöffskiMartin E. BlacksteinAxel Le CesneGiuseppe BadalamentiJianming XuDirk LaurentI. KussGeorge D. Demetri
Metrics
Citation History
Topics
Related Documents
Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial.
George D. DemetriPeter ReichardtYoon‐Koo KangJean‐Yves BlayHeikki JoensuuRobert G. MakiPiotr RutkowskiPeter HohenbergerHans GelderblomMichael LeahyMargaret von MehrenPatrick SchöffskiMartin E. BlacksteinAxel Le CesneGiuseppe BadalamentiJianming XuToshirou NishidaDirk LaurentIris KussPaolo G. Casalion behalf of GRID Investigators
Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial.
George D. DemetriPeter ReichardtYoon‐Koo KangJean‐Yves BlayHeikki JoensuuRobert G. MakiPiotr RutkowskiPeter HohenbergerHans GelderblomMichael LeahyMargaret von MehrenPatrick SchöffskiMartin E. BlacksteinAxel Le CesneGiuseppe BadalamentiJianming XuToshirou NishidaDirk LaurentIris KussPaolo G. Casalion behalf of GRID Investigators
Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial
Paolo G. CasaliP. ReichardtYoung Ae KangJean‐Yves BlayHeikki JoensuuRobert G. MakiPiotr RutkowskiPeter HohenbergerHans GelderblomM.G. LeahyMargaret von MehrenPatrick SchöffskiMartin E. BlacksteinA. Le CesneGiuseppe BadalamentiJiangtao XuToshirou NishidaDirk LaurentIris KussGoerge D. Demetri
Phase I Trial of Sunitinib Plus Imatinib in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
Antonio López–PousaL. Paz-AresCarles PericayXavier García del MuroM.J. Flor
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17
Chun‐Nan YehMing‐Huang ChenYen‐Yang ChenChing‐Yao YangChueh‐Chuan YenChin‐Yuan TzenLi‐Tzong ChenJen‐Shi Chen